176 related articles for article (PubMed ID: 31068366)
21. Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.
Chang HR; Park HS; Ahn YZ; Nam S; Jung HR; Park S; Lee SJ; Balch C; Powis G; Ku JL; Kim YH
BMC Cancer; 2016 Mar; 16():200. PubMed ID: 26955870
[TBL] [Abstract][Full Text] [Related]
22. Positive regulation of hepatic miR-122 expression by HNF4α.
Li ZY; Xi Y; Zhu WN; Zeng C; Zhang ZQ; Guo ZC; Hao DL; Liu G; Feng L; Chen HZ; Chen F; Lv X; Liu DP; Liang CC
J Hepatol; 2011 Sep; 55(3):602-611. PubMed ID: 21241755
[TBL] [Abstract][Full Text] [Related]
23. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
Maeda Y; Hwang-Verslues WW; Wei G; Fukazawa T; Durbin ML; Owen LB; Liu X; Sladek FM
Biochem J; 2006 Dec; 400(2):303-13. PubMed ID: 16895524
[TBL] [Abstract][Full Text] [Related]
24. Two novel cis-elements involved in hepatocyte nuclear factor 4α regulation of acyl-coenzyme A:cholesterol acyltransferase 2 expression.
Zhang Z; Liu J; Xi Y; Yang R; Chen H; Li Z; Liu D; Liang C
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):162-71. PubMed ID: 22155889
[TBL] [Abstract][Full Text] [Related]
25. Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4alpha (HNF4alpha) binding to the hnf4alpha gene in the liver.
Bailly A; Briançon N; Weiss MC
Biochimie; 2009 Sep; 91(9):1095-103. PubMed ID: 19540905
[TBL] [Abstract][Full Text] [Related]
26. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
[TBL] [Abstract][Full Text] [Related]
28. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
[TBL] [Abstract][Full Text] [Related]
29. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
Wang H; Lu J; Tang J; Chen S; He K; Jiang X; Jiang W; Teng L
BMC Cancer; 2017 Mar; 17(1):191. PubMed ID: 28292264
[TBL] [Abstract][Full Text] [Related]
30. Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator-activated receptor alpha.
Shin M; Kim I; Inoue Y; Kimura S; Gonzalez FJ
Mol Pharmacol; 2006 Oct; 70(4):1281-90. PubMed ID: 16807375
[TBL] [Abstract][Full Text] [Related]
31. RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer.
Zarei M; Lal S; Vaziri-Gohar A; O'Hayer K; Gunda V; Singh PK; Brody JR; Winter JM
Mol Cancer Res; 2019 Feb; 17(2):508-520. PubMed ID: 30266754
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin B.
Wang Z; Li ZX; Zhao WC; Huang HB; Wang JQ; Zhang H; Lu JY; Wang RN; Li W; Cheng Z; Xu WL; Di Zhu ; Zhou LS; Jiang W; Yu L; Liu JY; Luo C; Zhu H; Dan Ye ; Pan WJ; Ju JH; Dang YJ
Acta Pharmacol Sin; 2021 May; 42(5):801-813. PubMed ID: 32796956
[TBL] [Abstract][Full Text] [Related]
33. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
34. Construction of a plasmid vector for liver-specific inhibition of hepatocyte nuclear factor 4 alpha expression.
Song XQ; Chen EQ; Wang YB; Zhou TY; Liu L; Liu C; Cheng X; Tang H
Plasmid; 2012 Jan; 67(1):60-6. PubMed ID: 21907733
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestine.
Tegude H; Schnabel A; Zanger UM; Klein K; Eichelbaum M; Burk O
Drug Metab Dispos; 2007 Jun; 35(6):946-54. PubMed ID: 17344340
[TBL] [Abstract][Full Text] [Related]
36. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.
West AC; Tang K; Tye H; Yu L; Deng N; Najdovska M; Lin SJ; Balic JJ; Okochi-Takada E; McGuirk P; Keogh B; McCormack W; Bhathal PS; Reilly M; Oshima M; Ushijima T; Tan P; Jenkins BJ
Oncogene; 2017 Sep; 36(36):5134-5144. PubMed ID: 28481875
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer.
Wu F; Cheng G; Yao Y; Kogiso M; Jiang H; Li XN; Song Y
Med Chem; 2018; 14(7):715-724. PubMed ID: 29792149
[TBL] [Abstract][Full Text] [Related]
38. Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.
Tateishi K; Wakimoto H; Iafrate AJ; Tanaka S; Loebel F; Lelic N; Wiederschain D; Bedel O; Deng G; Zhang B; He T; Shi X; Gerszten RE; Zhang Y; Yeh JJ; Curry WT; Zhao D; Sundaram S; Nigim F; Koerner MVA; Ho Q; Fisher DE; Roider EM; Kemeny LV; Samuels Y; Flaherty KT; Batchelor TT; Chi AS; Cahill DP
Cancer Cell; 2015 Dec; 28(6):773-784. PubMed ID: 26678339
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment.
Lv DD; Zhou LY; Tang H
Exp Mol Med; 2021 Jan; 53(1):8-18. PubMed ID: 33462379
[TBL] [Abstract][Full Text] [Related]
40. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
